A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for ...
Herpes simplex virus (HSV) research continues to be a dynamic and interdisciplinary field encompassing virology, immunology, gene therapy and structural biology. Central to these studies is the ...
Researchers use cryo-EM and optical tweezers to investigate how an antiviral interacts with the herpes simplex virus.
Herpes simplex virus (HSV) encephalitis, caused by HSV types 1 and 2, is the most common sporadic viral encephalitis worldwide, with an annual incidence of around 2·2–4·6 per million people.1 Before ...
The incidence of neonatal herpes simplex virus (HSV) infections in the UK and Ireland increased dramatically over 15 years, and outcomes remained poor, with mortality and long-term neurologic ...
Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a clinical-stage biotechnology company, today announced a strategic partnership ...
Inhibiting the herpes simplex virus type 1 viral enzyme uracil-DNA glycosylase reactivates the natural defense protein apolipoprotein B mRNA editing enzyme, catalytic polypeptide-1 (APOBEC1) in the ...
Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells. A single dose of the modified virus increased T-cell, ...
While it may give billions of people worldwide painful cold sores, a common virus could be harnessed to provide a much-need new cancer treatment. This is the conclusion of a study by researchers with ...
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience.View full ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results